Is continuous positive airway pressure (CPAP) a new standard of care for type 1 respiratory failure in COVID-19 patients? A retrospective observational study of a dedicated COVID-19 CPAP service.
Rebecca NightingaleNneka NwosuFarheen KutubudinTom FletcherJoe LewisFrederick FrostKathryn HaighRyan RobinsonAyesha KumarGareth JonesDeborah BrownMichael AbouyannisMike BeadsworthPeter HampshireStephen AstonManish GautamHassan BurhanPublished in: BMJ open respiratory research (2020)
The aim of this case series is to describe and evaluate our experience of continuous positive airway pressure (CPAP) to treat type 1 respiratory failure in patients with COVID-19. CPAP was delivered in negative pressure rooms in the newly repurposed infectious disease unit. We report a cohort of 24 patients with type 1 respiratory failure and COVID-19 admitted to the Royal Liverpool Hospital between 1 April and 30 April 2020. Overall, our results were positive; we were able to safely administer CPAP outside the walls of a critical care or high dependency unit environment and over half of patients (58%) avoided mechanical ventilation and a total of 19 out of 24 (79%) have survived and been discharged from our care.
Keyphrases
- positive airway pressure
- respiratory failure
- mechanical ventilation
- obstructive sleep apnea
- sleep apnea
- sars cov
- healthcare
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- coronavirus disease
- intensive care unit
- infectious diseases
- palliative care
- ejection fraction
- emergency department
- mental health
- pain management
- patient reported outcomes
- adverse drug
- acute care